Scoop has an Ethical Paywall
Work smarter with a Pro licence Learn More
Top Scoops

Book Reviews | Gordon Campbell | Scoop News | Wellington Scoop | Community Scoop | Search

 

$200 Million Program Saves (Estimated) Three Lives

$200 Million Program Saves (Estimated) Three Lives

Dr Richard Arnold readying himself for a potential media onslaught regarding his vaccination study - Scoop Image

*******

Dr Richard Arnold, head of the Victoria University team which carried out an effectiveness study into the staggered roll-out of the MeNZB(TM) immunisation programme today told a media conference that an estimated two to three lives to date had been saved due to the $200 million vaccination program.

According to a Ministry of Health press release the Government committed $200 million to the Meningococcal Vaccine Strategy which has paid for the development of a strain-specific vaccine, clinical trials and implementation of our biggest mass immunisation campaign for all New Zealanders under 20 years old. A further $22 million has been allocated over the next three years to extend the programme.

At the time the vaccine was rolled out the Meningococcal B epidemic was decreasing throughout most of New Zealand however there was no evidence that the disease was waning in the northern part of New Zealand according to Meningococcal B Immunisation Programme Director Dr Jane O'Hallahan.

Dr O Hallahan pointed out that the estimates for how many cases had been prevented and how many lives had been saved were "conservative".

Advertisement - scroll to continue reading

Are you getting our free newsletter?

Subscribe to Scoop’s 'The Catch Up' our free weekly newsletter sent to your inbox every Monday with stories from across our network.

The Minister of Health Pete Hodgson announced in a press releases that "evidence released today demonstrating the effectiveness of the MeNZB vaccine confirms that the government's decision to invest in ending the Meningococcal B epidemic was the right one."

Following the Ministry Of Health press conference Don Matheson Deputy Director-General Public Health explained to Scoop that if you are looking at the cost benefit analysis of the vaccine it was necessary to look at how long the Meningococcal B epidemic would have lasted without intervention.

Listen to the media ask questions about the effectiveness of the $200 million Meningococcal B vaccine program

Scoop Audio.Scoop Streaming Audio: Meningococcal B vaccination Q and A 08.08.06


Click here to download file (mp3)

Listen to Dr Richard Arnold and Dr Jane O'Hallahan talk the media through Dr Arnold's effectiveness study

Scoop Audio.Scoop Streaming Audio: Meningococcal B vaccine briefing

Click here to download file(mp3)

ENDS

© Scoop Media

Advertisement - scroll to continue reading
 
 
 
Top Scoops Headlines

 
 
 
 
 
 
 
 
 
 
 
 

Join Our Free Newsletter

Subscribe to Scoop’s 'The Catch Up' our free weekly newsletter sent to your inbox every Monday with stories from across our network.